GLP Watchdog

Direct Meds vs Hims

Direct Meds has an open FDA warning letter dated September 9, 2025. Hims has an open FDA warning letter dated September 9, 2025. No price lines up like for like: Direct Meds and Hims publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Direct Meds / Hims

Featured pick (affiliate partner)

Direct Meds logo

Direct Meds

7.1/10

Hims logo

Hims

6.7/10

FDA warning letters
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded oral semaglutide
$149/moBrand-name semaglutide pill, medication only, membership extra
States
48 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Direct Meds
Visit Hims

Direct Meds is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hims pays us nothing. The scores are computed the same way for both and are shown as computed (Direct Meds 7.1, Hims 6.7). How we are paid

What the record shows

  1. 01

    Direct Meds has an open FDA warning letter dated September 9, 2025. Hims has an open FDA warning letter dated September 9, 2025.

  2. 02

    Direct Meds names no compounding pharmacy in our record. Hims sells brand-name medication only.

  3. 03

    No price lines up like for like: Direct Meds and Hims publish prices for different products.

  4. 04

    Only Direct Meds lists a price for compounded semaglutide injection, compounded tirzepatide injection and compounded oral semaglutide. Only Hims lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    Hims covers two states Direct Meds does not.

  6. 06

    Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days; Hims states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Direct Meds

Hims

Compounded semaglutide injection

$297/mo

$3,564 a year

Not sold or not priced
Compounded tirzepatide injection

$399/mo

$4,788 a year

Not sold or not priced
Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Compounded oral semaglutide

$249/mo

$2,988 a year

Not sold or not priced
Compounded oral tirzepatide

$299/mo

$3,588 a year

Not sold or not priced
Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, shipping
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
No
Yes, stated
Minimum term
90-day supply shipped at once, remaining months billed every 30 days
Monthly membership, auto-renews
Refunds
No refunds for medication already received; $35 disposal fee on returns
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Direct Meds: October 17, 2026. Hims: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Direct Meds

7.1/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Hims does not price
  • Price includes clinician visits
  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Minimum commitment before you can cancel
Visit Direct Meds

The case for Hims

6.7/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Direct Meds does not price
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

Scores

Direct Meds 7.1 · Hims 6.7 out of 10. Six weighted parts.

Value25%

4.2A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

4.5A
vs
B
6.0

Accessibility10%

9.7A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Direct Meds vs Hims: questions

Direct Meds has an open FDA warning letter dated September 9, 2025. Hims has an open FDA warning letter dated September 9, 2025. Letters are matched to a seller by company, domain and address, never by a similar name.
Direct Meds names no compounding pharmacy in our record. Hims sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: Direct Meds and Hims publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Direct Meds has a minimum term (90-day supply shipped at once, remaining months billed every 30 days). Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed.
Direct Meds is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hims pays us nothing. The scores are computed the same way for both and are shown as computed (Direct Meds 7.1, Hims 6.7).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks